Status:
COMPLETED
Short-Term Androgen Priming Before COS Using Aromatase Inhibitor and hCG During Early-Follicular-Phase GnRH Antagonist Administration - a Randomized Controlled Trial
Lead Sponsor:
Rigshospitalet, Denmark
Conditions:
Infertility
Eligibility:
FEMALE
18-39 years
Phase:
PHASE4
Brief Summary
We want to investigate if early follicular phase downregulation and androgen priming, by use of GnRH antagonist, aromatase inhibitor and hCG before COH in a short protocol, shows signs of improvement ...
Eligibility Criteria
Inclusion
- Indication and wish for IVF/ICSI treatment
- Womens age 20-39 years (both inclusive)
- Regular menstrual cycle within normal range
- Body Mass Index: 18-30 kg/m2 (both inclusive)
- Negative pregnancy test before treatment
- A maximum of 3 earlier IVF/ICSI treatments that did not result in pregnancy
Exclusion
- serious systemic disease
- Presence of polycystic ovarian syndrome (PCOS)
- Earlier poor response with less than 4 mature follicles
- Earlier participation in the investigation
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00286364
Last Update
April 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Fertility Clinic 4071, Copenhagen University Hospital Rigshospitalet
Copenhagen, Copenhagen East, Denmark, 2100